REFERENCES

• ConradoDJ.RogersHL.ZinehI.PacanowskiMA.Consistency of drug-drug and gene-drug interaction information in US FDA-approved drug labels.Pharmacogenomics.20131421522323327581
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Table of pharmacogenomic biomarkers in grug labeling. Available at: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm. Accessed October 2014.
   Google Scholar
• HicksJK.SwenJJ.ThornCF.et alClinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.Clin Pharm Ther.201393402408
   PubMed Web of Science ®Google Scholar
• WertzDC.Ethical, social and legal issues in pharmacogenomics.Pharmacogenomics J.2003319419612931132
   PubMed Web of Science ®Google Scholar
• Biological insights from 108 schizophrenia-associated genetic loci.Nature.201451142142725056061
   PubMed Web of Science ®Google Scholar
• LeeSH.RipkeS.NealeBM.et alGenetic relationship between five psychiatric disorders estimated from genome-wide SNPs.Nat Genet.20134598499423933821
   PubMed Web of Science ®Google Scholar
• International Schizophrenia Consortium: Purcell SM, Wray NR, Stone JR, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.Nature.200946074875219571811
   PubMed Web of Science ®Google Scholar
• Cross-Disorder Group of the Psychiatric Genomics C. Identification of risk loci with shared effects on five major psychiatric disorders: a genomewide analysis.Lancet.20133811371137923453885
   PubMed Web of Science ®Google Scholar
• GamazonER.BadnerJA.ChengL.et alEnrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants.Mol Psychiatry.20131834034622212596
   PubMed Web of Science ®Google Scholar
• JiY.BiernackaJM.HebbringS.et alPharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics.Pharmacogenomics J.20131345646322907730
   PubMed Web of Science ®Google Scholar
• GershonES.GrennanK.BusnelloJ.et alA rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain.Mol Psychiatry.20131989089423979604
   PubMed Web of Science ®Google Scholar
• FerreiraMA.O'DonovanMC.MengYA.et alCollaborative genomewide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.Nat Genet.2008401056105818711365
   PubMed Web of Science ®Google Scholar
• LevyNA.JanicakPG.Calcium channel antagonists for the treatment of bipolar disorder.Bipolar Disord.2000210811911252650
   PubMed Web of Science ®Google Scholar
• AkpudoHA.AleksicBG.AlkelaiAH.et alSummaries of oral sessions at the XXI World Congress of Psychiatric Genetics, Boston, Massachusetts, 17-21 October 2013: state of the field.Psychiatr Genet.20142412515024912047
   PubMed Web of Science ®Google Scholar
• MalhotraD.McCarthyS.MichaelsonJJ.et alHigh frequencies of de novo CNVs in bipolar disorder and schizophrenia.Neuron.20117295196322196331
   PubMed Web of Science ®Google Scholar
• NurnbergerJl.Jr.KollerDL.JungJ.et alIdentification of pathways for bipolar disorder: a meta-analysis.JAMA Psychiatry.2014716576424718920
   PubMed Web of Science ®Google Scholar
• FromerM.PocklingtonAJ.KavanaghDH.et alDe novo mutations in schizophrenia implicate synaptic networks.Nature.201450617918424463507
   PubMed Web of Science ®Google Scholar
• GrennanKS.ChenC.GershonES.LiuC.Molecular network analysis enhances understanding of the biology of mental disorders.BioEssays.20143660661624733456
   PubMed Web of Science ®Google Scholar
• IancuOD.DarakjianP.MalmangerB.WalterNA.McWeeneyS.HitzemannR.Gene networks and haloperidol-induced catalepsy.Genes Brain Behav.201211293721967164
   PubMed Web of Science ®Google Scholar
• KorostynskiM.PiechotaM.DzbekJ.et alNovel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.BMC Genomics.20131460624010892
   PubMed Web of Science ®Google Scholar
• MiguezDG.Network nonlinearities in drug treatment.Interdiscip Sci.20135859423740389
   PubMed Web of Science ®Google Scholar
• RosenfeldS.Biomolecular self-defense and futility of high-specificity therapeutic targeting.Gene Regul Syst Bio.2011589104
   PubMedGoogle Scholar
• RichelsonE.Multi-modality: a new approach for the treatment of major depressive disorder.Int J Neuropsychopharmacol.201311023363735
   PubMed Web of Science ®Google Scholar
• DobrinR.ZhuJ.MolonyC.et alMulti-tissue coexpression networks reveal unexpected subnetworks associated with disease.Genome Biol200910R5519463160
   PubMed Web of Science ®Google Scholar
• LopesTJ.SchaeferM.ShoemakerJ.et alTissue-specific subnetworks and characteristics of publicly available human protein interaction databases.Bioinformatics.2011272414242121798963
   PubMed Web of Science ®Google Scholar
• ZhangB.HorvathS.A general framework for weighted gene co-expression network analysis.Stat Appl Genet Mol Biol.20054Article1716646834
   PubMed Web of Science ®Google Scholar
• CaiC.LangfelderP.FullerTF.et alIs human blood a good surrogate for brain tissue in transcriptional studies?BMC Genomics.20101158920961428
   PubMed Web of Science ®Google Scholar
• FullerTF.GhazalpourA.AtenJE.DrakeTA.LusisAJ.HorvathS.Weighted gene coexpression network analysis strategies applied to mouse weight.Mamm Genome.20071846347217668265
   PubMed Web of Science ®Google Scholar
• KangHJ.KawasawaYl.ChengF.et alSpatio-temporal transcriptome of the human brain.Nature.201147848348922031440
   PubMed Web of Science ®Google Scholar
• TorkamaniA.DeanB.SchorkNJ.ThomasEA.Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia.Genome Res.20102040341220197298
   PubMed Web of Science ®Google Scholar
• ChenC.ChengL.GrennanK.et alTwo gene co-expression modules differentiate psychotics and controls.Mol Psychiatry.2013181308131423147385
   PubMed Web of Science ®Google Scholar
• ChoiDW.Calcium and excitotoxic neuronal injury.Ann N Y Acad Sci.19947471621717847669
   PubMed Web of Science ®Google Scholar
• ShaoL.VawterMP.Shared gene expression alterations in schizophrenia and bipolar disorder.Biol Psychiatry.200864899718191109
   PubMed Web of Science ®Google Scholar
• BarashCI.Ethical Issues in Pharmacogenetics. Action Bioscience; 2013. Available at: http://www.actionbioscience.org/biotechnology/ethical_issues_in_pharacogenetics.html. Accessed October 2014. 2013170968976
   Google Scholar
• GershonES.Alliey-RodriguezN.New ethical issues for genetic counseling in common mental disorders.Am J Psychiatry.201317096897623897273
   PubMed Web of Science ®Google Scholar
• WernigM.ZhaoJP.PruszakJ.et alNeurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease.Proc Natl Acad Sci USA.20085856586118391196
   PubMed Web of Science ®Google Scholar
• TuttonR.Pharmacogenomic biomarkers in drug labels: what do they tell us?Pharmacogenomics.20141529730424533709
   PubMed Web of Science ®Google Scholar